Company: SYRA
Filing Date: 2025-02-05
Form Type: S-3/A
Source: 0001493152-25-005032
Chunk: 10

Company: Syra Health Corp
Filing Date: 2025-02-05
Form: S-3/A
Chunk 10
---

| ● | We                                                                                                                                
 are subject to federal and state healthcare industry regulation including conduct of operations, licensing, costs and payment for 
 services and payment for referrals as well as laws regarding government contracting.                                              |

Risks Related to Our Class A Common Stock

| ● | The                                                                                                                                      
 dual-class structure of our common stock as contained in our Amended and Restated Certificate of Incorporation, as amended (“Certificate 
 of Incorporation”), has the effect of concentrating voting control with those stockholders who hold our Class B common stock.            
 This ownership will limit or preclude your ability to influence corporate matters, including the election of directors, amendments       
 of our organizational documents, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate 
 transactions requiring stockholder approval, and that may adversely affect the trading price of our Class A Common Stock.                |
| ● | Our                                                                                                                                      
 principal stockholders will continue to have significant influence over the election of our board of directors and approval of any       
 significant corporate actions, including any sale of our Company.                                                                        |

JOBS Act

On April 5, 2012, the JOBS Act was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (“Securities Act”), for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have chosen to take advantage of the extended transition periods available to emerging growth companies under the JOBS Act for complying with new or revised accounting standards until those standards would otherwise apply to private companies provided under the JOBS Act. As a result, our financial statements may not be comparable to those of companies that comply with public company effective dates for complying with new or revised accounting standards.

We are evaluating the benefits of relying on other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company,” we intend to rely on certain of these exemptions, including without limitation, (i) providing an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, as amended, and (ii) complying with any